UBM International Media, a wholly owned subsidiary of United Business Media plc (LSE: UBM) and AIM, the international association and recognized authority on bar code, RFID, and enterprise mobile computing, today announced that the FDA's Jay Crowley, senior advisor for patient safety, Center for Devices and Radiological Health, will deliver the keynote address for the Track & Trace Virtual Trade Show on opening day, December 2nd in the online presentation theater.
Speaking about "The Upside of a Unique Device Identification (UDI) Mandate", Crowley will outline the urgent need for traceability for medical devices and what the healthcare community needs to know to be ready. Included in the address will be practical ways that the device manufacturers, healthcare providers, and patients will be affected by upcoming changes.
"Tracking and tracing the path of medical devices from manufacture, distribution, up to the point of use and possible recall, including ultimate end-of-product life, has implications of broad proportions within today's healthcare community," states Crowley. "The Virtual Trade Show provides a unique opportunity to raise awareness about the importance of unique identification and its role in improving patient safety."
The Track & Trace Virtual Trade Show is the first exclusively online exhibition and conference that uses cutting-edge technology to connect a larger community of industry professionals, decision-makers and leading suppliers from the auto ID market, in real time.
Attendee registration is complimentary and will open October 19. More information is available online at www.ubmtrackandtrace.com.
Exploring AI's role in transforming healthcare diagnosis and treatment